ロード中...
The Development of Hypogonadotropic Hypogonadism After Starting Low Dose Mifepristone for Cushing’s Syndrome
Background: Mifepristone is an antiprogesterone that has been studied in females and has shown central effects including suppressing LH surges. There is a paucity of information about how it effects males. Clinical Case: 65-year-old male with bilateral adrenal macronodular hyperplasia noted on a pas...
保存先:
| 出版年: | J Endocr Soc |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090319/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.325 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|